OSLO (Reuters) -Norway will not resume its use of the COVID-19 vaccine made by AstraZeneca due to a risk of rare but harmful side-effects, newspaper VG reported on Wednesday.
Prime Minister Erna Solberg is expected to announce at 1600 GMT whether Norway will resume the use of the AstraZeneca shot, as well as the government's decision on Johnson & Johnson's inoculation.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
